Renal Cell Cancer, Recurrent Terminated Phase 2 Trials for Interferon alfa-2b (DB00105)

Also known as: Recurrent Renal Cell Cancer

IndicationStatusPhase
DBCOND0082537 (Renal Cell Cancer, Recurrent)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00098618Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney CancerTreatment